The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to targeted and immune therapy in patients with NSCLC and BRAF non-V600E mutations: A retrospective, multicenter analysis within the national Network Genomic Medicine Lung Cancer (nNGM) in Germany.
 
Cornelia Kropf-Sanchen
Honoraria - Amgen; Art Tempi; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; Daiichi Sankyo; MSD; Onkowissen; Pfizer; Roche; Streamedup!
Consulting or Advisory Role - Amgen; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; Daiichi Sankyo; MSD; Onkowissen; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Janssen
 
Anna Rasokat
No Relationships to Disclose
 
Petros Christopoulos
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); Roche (Inst); Takeda (Inst)
 
Felix Carl Saalfeld
Honoraria - AstraZeneca; GWT; Novartis; Pfizer; Pfizer; Takeda; Thieme
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Janssen; Janssen; Pfizer
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Takeda
 
Thomas Wehler
No Relationships to Disclose
 
Maximilian Rost
No Relationships to Disclose
 
Jonas Kulhavy
No Relationships to Disclose
 
Niels Reinmuth
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck KGaA; Merck Sharp & Dohme; Pfizer; Roche; Sanofi Aventis GmbH; Takeda
Travel, Accommodations, Expenses - Janssen
 
Christian Schulz
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
 
Juergen Wolf
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen; Lilly; Loxo; Loxo/Lilly; Merck; Mirati Therapeutics; MSD; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; Merck; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Sanofi
 
Reinhard Buettner
Stock and Other Ownership Interests - Gnothis
Honoraria - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Illumina; Merck Serono; MSD; Novartis; Pfizer; Qiagen; Roche
Research Funding - Roche (Inst)
 
Sabine Merkelbach-Bruse
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Nadine Gaisa
No Relationships to Disclose
 
Gerlinde Schmidtke-Schrezenmeier
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Pfizer; Roche; Takeda
 
Maike Collienne
Research Funding - Oncolytics (Inst)
 
Melanie Janning
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; Takeda
Consulting or Advisory Role - Amgen; MSD
Speakers' Bureau - AstraZeneca; Novartis; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Michael Thomas
Honoraria - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Janssen Oncology; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
 
Matthias Scheffler
Honoraria - Amgen; AstraZeneca/Daiichi Sankyo; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Siemens Healthineers; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Janssen Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Siemens Healthineers; Takeda
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Dracen (Inst); Janssen (Inst); Novartis (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Janssen; Pfizer
 
Tilman Brummer
No Relationships to Disclose
 
Sonja Loges
Honoraria - Sanofi
Consulting or Advisory Role - Abbvie; AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Medac; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Medac; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - ADC Therapeutics; BerGenBio; Bristol-Myers Squibb; Lilly; Roche